Helicobacter pylori and gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 3, 2010, Pages 583-588

  Pandey, Renu ^b   Misra, Vatsala ^a   Misra, S P ^a   Dwivedi, Manisha ^a   Kumar, Ajay ^b   Tiwari, Balesh Kumar ^b  

^a MLN MEDICAL COLLEGE   (India)

^b UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Epidemiology; Factors; Gastric cancer; Helicobacter pylori

Indexed keywords

EID: 78650712007     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Alagnatham TP, Pai M, Vaidehi T, et al (1999). Seroepidemiology of Helicobacter pylori infection in an urban, upper class population in Chennai. Indian J Gastroenterol, 18, 66-8.
2. Blaser MJ, Chyou PH, Nomura A (1995). Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res, 55, 562-5.
3. Boussioutas A, Li H, Liu J, et al (2003). Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res, 63, 2569-77.
4. Buiatti E, Palli D, Decarli A, et al (1989). A case-control study of gastric cancer and diet in Italy. Int J Cancer, 44, 611-6.
5. Buiatti E, Palli D, Decarli A, et al (1990). A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer, 45, 896-901.
6. Correa P, Ruiz B, Campylobacter pylori and gastric cancer. In Rathbone BJ, Heatley RV. Eds. Campylobacter pylori and gastro duodenal disease. Oxford: Blackwell Scientific Publication 1989, 139-45.
7. Correa P (1995). Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol, 19, 37-43.
8. Chin L, Artandi SE, Shen Q, et al (1999). p53 deficiency rescues the adverse effect of telomerase loss and co-operates with telomere dysfunction to accelerate carcinogenesis. Cell, 97, 527-38.
9. Correa P (1992). Human gastric carcinogenesis: A multistep and multifactorial process-fist American Cancer Society Award Lecture on Cancer epidemiology and prevention. Cancer Res, 52, 35-40.
10. Correa P, Haenszel W, Cuello C, et al (1990). Gastric precancerous process in a high risk population: crosssectional studies. Cancer Res, 50, 4731-6.
11. Correa P, Haenszel W, Cuello C, et al (1990). Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res, 50, 4737-40.
12. Fontham ET (1994) Vitamin C, vitamin C-enriched foods and cancer. In: B Frei, editor. Natural antioxidants in human health and disease. San Diego (CA), Academic Press, 157-97.
13. Forman D, Stacery AR, Sitas F, et al (1991). Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ, 302, 1302-5.
14. Forman D, Webb P, Parsonnet J (1994). H. pylori and gastric cancer. Lancet, 343, 243-4.
15. Figueiredo C, Machado JC, Pharoah P, et al (2002). Helicobacter pylori and interleukin genotyping: an opportunity to identify High-risk individuals for gastric carcinoma. J Natl Cancer Inst, 94, 1680-7.
16. El-Omar E, Carrington M, Chow W, et al (2000). Interleukin-1 polymorphism: associated with increase risk of gastric cancer. Nature, 404, 398-402.
17. Holcombe C (1992). Helicobacter pylori: the African enigma. Gut, 33, 429-31.
18. Hansson LE, Nyren O, Hsing AW, et al (1996). The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med, 335, 242-9.
19. Helicobacter pylori and cancer collaborative group (2001). Gastric cancer and H.pylori: A combined analysis of 12 case control studies nested with in prospective cohorts. Gut, 49, 347-53.
20. International Agency for Research on Cancer (IARC) Working Group (1994). IARC monographs on the evaluation of carcinogenic risk to humans. Schistosomes, liver flukes and Helicobacter pyloriLyon (France). IARC, 61.
21. Ishida M, Gomyo Y, Ohfugi S, et al (1997). Evidence that expression of a mutated p53 attenuates apoptotic sell death in human gastric intestinal type carcinomas in-vivo. Jpn J Cancer Res, 88, 468-75.
22. Meining A, Reidi B, Stolte M (2002). Features of gastritis predisposing to gastric adenoma and early gastric cancer. J Clin Pathol, 55, 770-3.
23. Malhotra SL (1967). Geographical distribution of gastrointestinal cancer in India with special reference to causation. Gut, 8, 361-72.
24. Misra V, Misra SP, Singh MK, et al (2007). Prevalence of H.pylori in patients with gastric cancer. Indian J Pathol Microbiol, 50, 702-7.
25. Magnusson PKE, Eurath H, Erikson I (1996). Gastric cancer and human leukocytes antigen. Cancer Res, 56, 3238-43
26. Marshall B (1983). The discovery that Helicobacter pylori, a spiral bacterium, caused peptic ulcer disease. Helicobacter Pioneers, ,BOOK???? 165-202.
27. Miller MJ, Correa P (1998). Nitrogen oxides and the gastric precancerous process. In: RH Hunt and GN Tytgat, editors. Helicobacter pylori: basic mechanisms to clinical cure. Boston (MA). Kluger Academic Publishers, 308-14.
28. Moss SF (1998). Helicobacter pylori and apoptosis. Yale J Biol Med, 71, 53-61.
29. Mizuki I, Shimoyama T, Fukuda S, et al (2000). Association of gastric epithelial apoptosis with the ability of Helicobacter pylori to induce a neutrophil oxidative burst. J Med Microbiol, 49, 521-4.
30. Neil GA (1997). Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era. Ad hoc committee on FDA-related matters. Am J Gastroenterol, 92, 387-93.
31. Nomura A, Stemmerman GN, Chyou PH, et al (1991). Helicobacter pylori infection and gastric adenocarcinoma among Japanese in Hawaii. N Engl J Med, 325, 1132-6.
32. Olson JW, Maier RJ (2002). Molecular hydrogen as energy source for Helicobacter pylori. Science, 298, 1788-90.
33. Parsonnet J, Friedman GD, Yandersteen DP, et al (1991). H.pylori infection and risk of gastric carcinoma. N Engl J Med, 325, 1127-33.
34. Prasad S, Matham M, Chandy G, et al (1994). Prevalence of Helicobacter pylori in Southern Indian controls and patients with gastroduodenal disease. J gastroenterol Hepatol, 9, 501-6.
35. Parsonnet J, Vandersteen D, Goates J, er al (1991). Helicobacter pylori infection in intestinal and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst, 83, 640-3.
36. Parsonnet J, Friedman GD, Vandersteen DP, et al (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med, 325, 1127-31.
37. Quigley MM, Eslick GD (2006). Helicobacter pylori infection cancer? A review of epidemiological meta analytic and experimental evidence. World J gastroenterol, 12, 2991-9.
38. Reis C, David L, Correa P, et al (1999). Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res, 59, 1003-7.
39. Stark RM, Gerwig GJ, Pitman RS, et al (1999). Biofilm formation by Helicobacter pylori Lett. Appl Microbiol, 28, 121-6.
40. Talley NJ, Zinsmeister AR, Weaver A, et al (1991). Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst, 83, 1734-9.
41. Uemura N, Okamoto S, Yamamoto S, et al (2001). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 345, 784-9.
42. Van Doorn LJ, Figuieredo C, Megraud F, et al (1999). Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology, 116, 823-30.
43. Vaucher C, Janvier B, Nousbaum JB, et al (2000). Antibody response of patients with Helicobacter pylori related gastric adenocarcinoma: Significance of Anti cagA antibodies. Clin Diagn Lab Immunol, 7, 463-7.
44. Yamaoka Y (2008). Helicobacter pylori: Molecular Genetics and Cell Biology. Caister Academic Press, ISBN 1-904455-31-X
45. Zinsmeister AR, Weaver A, Eugine P, et al (1991). Gastric adenocarcinoma and H.pylori infection. J Natl Cancer Inst, 83, 1734-9.
46. Zhang ZW, Farting MJ (1999). Molecular mechanism of H.pylori associated gastric carcinogenesis. World J Gastroenterol, 5, 369-74.